129 related articles for article (PubMed ID: 29911320)
21. Quantitation of house dust mites and house dust mite allergens in the microenvironment of dogs.
Randall A; Hillier A; Cole LK; Kwochka KW; Needham G; Wassom DL
Am J Vet Res; 2003 Dec; 64(12):1580-8. PubMed ID: 14672439
[TBL] [Abstract][Full Text] [Related]
22. Allergen content in dust from homes and schools in northern Norway in relation to sensitization and allergy symptoms in schoolchildren.
Dotterud LK; Van TD; Kvammen B; Dybendal T; Elsayed S; Falk ES
Clin Exp Allergy; 1997 Mar; 27(3):252-61. PubMed ID: 9088651
[TBL] [Abstract][Full Text] [Related]
23. Establishing an experimental model for canine atopic dermatitis through epicutaneous application of
Kim SW; Kim JH
Front Vet Sci; 2022; 9():1015915. PubMed ID: 36337184
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of house dust mites and house dust mite allergens in the microenvironment of dogs.
Randall A; Hillier A; Cole LK; Kwochka KW; Needham G; Wassom DL
Am J Vet Res; 2003 Oct; 64(10):1301-9. PubMed ID: 14596470
[TBL] [Abstract][Full Text] [Related]
25. Effect of indoor house dust mite concentration on canine atopic dermatitis.
Kim J; Lee JH; Song Y; Kim HJ
Front Vet Sci; 2023; 10():1078306. PubMed ID: 36816188
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of sublingual immunotherapy with Dermatophagoides farinae vaccine in a murine atopic dermatitis model.
Liu L; Guo D; Liang Q; Ding S; Wu B; Zhang L; Li Q
Clin Exp Allergy; 2015 Apr; 45(4):815-22. PubMed ID: 25258013
[TBL] [Abstract][Full Text] [Related]
27. Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy.
Rodinkova VV; Yuriev SD; Kryvopustova MV; Mokin VB; Kryzhanovskyi YM; Kurchenko AI
Front Immunol; 2022; 13():848616. PubMed ID: 35392080
[TBL] [Abstract][Full Text] [Related]
28. Der f 35: An MD-2-like house dust mite allergen that cross-reacts with Der f 2 and Pso o 2.
Fujimura T; Aki T; Isobe T; Matsuoka A; Hayashi T; Ono K; Kawamoto S
Allergy; 2017 Nov; 72(11):1728-1736. PubMed ID: 28439905
[TBL] [Abstract][Full Text] [Related]
29. Identification, characterization, and cloning of a complementary DNA encoding a 60-kd house dust mite allergen (Der f 18) for human beings and dogs.
Weber E; Hunter S; Stedman K; Dreitz S; Olivry T; Hillier A; McCall C
J Allergy Clin Immunol; 2003 Jul; 112(1):79-86. PubMed ID: 12847483
[TBL] [Abstract][Full Text] [Related]
30. Specific Dermatophagoides farinae extract for canine immunotherapy.
Moya R; Ramió-Lluch L; Parody N; Brazis P; Puigdemont A; Carnés J
Vet Dermatol; 2021 Apr; 32(2):131-e29. PubMed ID: 33112005
[TBL] [Abstract][Full Text] [Related]
31. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
van Amersfort K; Vernooij JCM; van der Lee A
Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
[TBL] [Abstract][Full Text] [Related]
33. IgE sensitivity and cross-reactivity to crude and purified mite allergens (Der f 1, Der f 2, Der p 1, Der p 2) in atopic dogs sensitive to Dermatophagoides mite allergens.
Masuda K; Tsujimoto H; Fujiwara S; Kurata K; Hasegawa A; Yasueda H; Yamashita K; DeBoer DJ; de Weck AL; Sakaguchi M
Vet Immunol Immunopathol; 1999 Dec; 72(3-4):303-13. PubMed ID: 10628674
[TBL] [Abstract][Full Text] [Related]
34. Characterization and cloning of a major high molecular weight house dust mite allergen (Der f 15) for dogs.
McCall C; Hunter S; Stedman K; Weber E; Hillier A; Bozic C; Rivoire B; Olivry T
Vet Immunol Immunopathol; 2001 Feb; 78(3-4):231-47. PubMed ID: 11292526
[TBL] [Abstract][Full Text] [Related]
35. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).
DeBoer DJ; Verbrugge M; Morris M
Vet Dermatol; 2016 Apr; 27(2):82-7e23. PubMed ID: 26749020
[TBL] [Abstract][Full Text] [Related]
36. Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.
Marsella R; Segarra S; Ahrens K; Alonso C; Ferrer L
BMC Vet Res; 2020 Mar; 16(1):92. PubMed ID: 32197613
[TBL] [Abstract][Full Text] [Related]
37. Identification of Der f 23 as a new major allergen of Dermatophagoides farinae.
He Y; Dou C; Su Y; Chen J; Zhang Z; Zhao Z; Chen J; Ji K
Mol Med Rep; 2019 Aug; 20(2):1270-1278. PubMed ID: 31173194
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
Zhou J; Chen S; Song Z
Allergy Asthma Proc; 2021 Mar; 42(2):e47-e54. PubMed ID: 33685566
[No Abstract] [Full Text] [Related]
39. Incidence of anti-Der f 2 and anti-Zen 1-specific immunoglobulin E antibodies in atopic dogs from South-East England.
Patel A; Curtis CF; Cerundolo R
Vet Rec; 2019 Mar; 184(10):317. PubMed ID: 30674643
[TBL] [Abstract][Full Text] [Related]
40. Lack of Interference of Oclacitinib with the results of intradermal testing or allergen-specific IgE serology in Dermatophagoides farinae-sensitized beagle dogs.
Aleo MM; Messamore J; Nieto BA; Fleck TJ; Humphrey WR; Coscarelli EM; Mahabir SP; McCall RB; Gonzales AJ
Vet Immunol Immunopathol; 2023 Feb; 256():110537. PubMed ID: 36603446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
